November Webinars and Conferences

I wanted to extend an invitation that there will be three events coming this month on the importance of clinical trial simulation and adaptive trial design.  The first is a webinar on Wednesday, November 14, at 10am EST with Tessella who is Berry Consultants partner in the development of our simulation software FACTS.  During the webinar, I will demonstrate and provide examples of the benefits and needs of examining single trial simulations.  For more details and registration for the free webinar, please click here.

The second event is a webinar on "Incorporating Adaptive Trial Design Approaches in Oncology Clinical Trials" on Thursday, November 15, at 11am EST.   I will join experts from PPD to discuss the statistical component of adaptive trial design and how it can benefit clinical trials.  Register and attend this event at the Webcast Website.

Lastly, is the upcoming "DIA Adaptive Designs in Clinical Trials – Overcoming Persistent Barriers" Conference on November 29-30 in Washington, DC.  I will be presenting during the 2nd day's morning session on the importance of trial simulation.  For details and registration, please visit the conference website.

Join me at these events, and learn more about adaptive designs and the critical aspect for simulations in clinical trial designs.

More Recent News

February 2024 QUOTES Webinar

Berry Consultants will be hosting a webinar on the optimization of a clinical trial design by estimating its impact on the expected net present value of a drug development program using the software QUOTES (Quantification and Optimization of Trial Expectations Simulator).

Blog: Precision Promise Adaptive Platform Trial update

Blog by: Kert Viele News from the Precision Promise platform trial. Precision Promise is an adaptive platform trial investigating potential therapies for pancreatic cancer,

January 2024 FACTS Webinar

The Berry Consultants software team will be hosting its January FACTS webinar next Friday, January 19th at 11am EST to present the development plans for adding an ordinal endpoint option to the trial simulator.

Blog: Comments on the draft FDA master protocol guidance

Blog by: Kert Viele The FDA draft master protocol guidance is out Comments are due by February 22. Here are some preliminary thoughts and